Biochemical aspects of lithium in affective disorders.
D000342:Affective Symptoms / Q000188:drug therapy / Q000378:metabolism*; D000818:Animals; D001714:Bipolar Disorder / Q000188:drug therapy / Q000378:metabolism*; D002254:Carbonates; D002395:Catecholamines / Q000378:metabolism; D002462:Cell Membrane / Q000187:drug effects; D006801:Humans; D008094:Lithium / Q000097:blood / Q000134:cerebrospinal fluid / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D012964:Sodium / Q000494:pharmacology
D002254:Carbonates; D002395:Catecholamines; D008094:Lithium; D012964:Sodium; D009638:Norepinephrine